Simultaneous integrated boost for adjuvant treatment of breast cancer--intensity modulated vs. conventional radiotherapy: the IMRT-MC2 trial.

showed a reduction of 36% and 57% at 4 and 8 cm respectively from the center of the medial border of the tangential field on the contralateral breast when IMRT was used compared to 3D-technique, a result which was found to be highly significant [ 23 ].

also in 82,756 other papers

Still, the study showed a slight trend in favor of IMRT with the 7-year freedom from ipsilateral breast tumor recurrence value found to be 95% for IMRT and 90% for conventional radiotherapy.

also in 2,443 other papers